Sunday treat for anyone reading this.
You know when you see a stock that goes bananas and you're like hrmmmmmm. It was trading like 50,000 shares a day before the breakout. Then it trades a few million and re-rates materially. Never returning to the low volume again. As markets take notice of the companies world changing tech.
You say to yourself. Wow. I am just an individual. I could have filled a position in that volume in a day or two had I just found it early enough. Then you watch the stock go on to multiply in just a short period of 4-8-16 months etc. and beyond.
Majority of investors in these markets have this life experience.
Don't let $APC.v. Be that memory for you. ;-)
$APC.v is a conjugation chemotherapy company. They use patented biotechnology to enhance the strength of existing chemotherapy drugs and are trying to invent their own.
By strengthening the chemo with conjugation. It reduces toxic breakdown contacting healthy cells en route to payload delivery.
The benefit is chemotherapy is more effective and causes less off target toxicity. Which contributes to harmful chemotherapy side effects.
The incoming CEO has spent 15+ years going to Ivey league and industry leading universities in Boston and New York. I think it's important to acknowledge the possibility, that this incoming CEO could have a lot of deep pocketed support behind him.
It's support like that of Wall st, that often extremely legitimate businesses are born from.
Still very early. Get it and forget it!
GLTA!